BOTTOM LINE: The New York Mets take on the Atlanta Braves after Brett Baty had four hits on Friday in a 12-7 win over the Braves. Atlanta is 58-70 overall and 32-32 in home games. The Braves are sixth ...

In a two-day interview Ghislaine Maxwell was asked about her relationship with Jeffrey Epstein and conspiracy theories ...

George Lopez, Jesse Garcia and Al Madrigal are among the new additions to the one-night-only virtual table read of the 2007 ...

BOTTOM LINE: The Atlanta Braves open a three-game series at home against the New York Mets on Friday. Atlanta has a 32-31 record in home games and a 58-69 record overall. The Braves have hit 143 total ...

Detailed price information for Moonlake Immunotherapeutics (MLTX-Q) from The Globe and Mail including charting and trades.

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the appointment of James M. Daly to its Board of Directors ...

MDGL wins EU nod for Rezdiffra as the first and only approved MASH therapy. The drug's launch in Europe is expected in the fourth quarter of 2025.

Madrigal Pharmaceuticals’ Rezdiffra (resmetirom) has been approved in Europe for the treatment of metabolic ...

Lebowitz covers the Healthcare sector, focusing on stocks such as Incyte, Schrodinger, and Madrigal Pharmaceuticals. Viking Therapeutics has an analyst consensus of Strong Buy, with a price target ...

Investing.com -- Madrigal Pharmaceuticals (NASDAQ: MDGL) stock declined 4% in pre-market trading Monday after the FDA ...